Search

everythinglearnresearchcommunity

for

Search:↓

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Cochrane and non-Cochrane drug safety reviews report well in PRISMA but poorly in PRISMA harms, with non-Cochrane needing improvement.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

The document concludes that the new expert system can assess the risk of PCOS effectively despite uncertainties in diagnosis.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Women with PCOS experience more psychological symptoms and need emotional support.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

QMSI effectively maps and quantifies drug distribution in skin tissues.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

The study found a link between the severity of Lichen Planopilaris seen by doctors and the details seen under a microscope, and created a new way to measure this severity.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

A new method uses expert reviews of home videos to objectively assess children's developmental milestones in single-arm trials.

People with mycosis fungoides/Sézary syndrome have a much lower quality of life.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

QMSI is a valuable method for studying drug penetration in skin tissues.

The Spanish version of the Hair Specific Skindex-29 is a reliable tool for measuring quality of life in Spanish-speaking women with hair loss.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

The questionnaire is valid and reliable but needs more testing for future predictions.

VESALT improves alopecia areata assessment by including non-scalp areas and is reliable and user-friendly.